Atlas Trials

Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

Clinical trial NCT05769868 · RECRUITING

Trial details

NCT number
NCT05769868
Sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
CirrhosisDiabetes MellitusOncologic Disorders
Start date
2023-04-18
Primary completion
2027-03-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.